Select a medication above to begin.
Leukeran
chlorambucil
Black Box Warnings .
Myelosuppression
may severely suppress bone marrow fxn
Carcinogen
human carcinogen
Mutagen/Teratogen
probably mutagenic and teratogenic in humans
Infertility
produces human infertility
Adult Dosing .
Dosage forms: TAB: 2 mg
Special Note
- [uses, dosing may vary]
- Info: refer to institution protocols and pkg insert prior to prescribing for uses and dosing incl. toxicity-related dose adjustments
Hodgkin lymphoma
- [0.2 mg/kg/dose PO qd x3-6wk]
non-Hodgkin lymphoma
- [0.1 mg/kg/dose PO qd x3-6wk]
CLL
- [0.1 mg/kg/dose PO qd x3-6wk]
- Alt: start 0.4 mg/kg/dose PO x1 intermittently, q2wk, or qmo, may incr. by 0.1 mg/kg
renal dosing
- [adjust dose amount]
- CrCl 10-50: decr. usual dose by 25%; CrCl <10: decr. usual dose by 50%
- HD: decr. usual dose by 50%; no supplement after dialysis; PD: decr. usual dose by 50%; no supplement
hepatic dosing
- [see below]
- hepatic impairment: consider decr. usual dose
Peds Dosing .
- Dosage forms: TAB: 2 mg
nephrotic syndrome (off-label)
- [0.1-0.2 mg/kg/dose PO qd]
- Info: use w/ prednisone
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]